136 related articles for article (PubMed ID: 11003361)
1. Therapy of visceral leishmaniasis in renal transplant recipients intolerant to pentavalent antimonials.
Llorente S; Gimeno L; Navarro MJ; Moreno S; Rodriguez-Gironés M
Transplantation; 2000 Sep; 70(5):800-1. PubMed ID: 11003361
[TBL] [Abstract][Full Text] [Related]
2. Visceral leishmaniasis: a rare cause of post-transplant fever and pancytopenia.
Rajaram KG; Sud K; Kohli HS; Gupta KL; Sakhuja V
J Assoc Physicians India; 2002 Jul; 50():979-80. PubMed ID: 12126362
[TBL] [Abstract][Full Text] [Related]
3. [Visceral leishmaniasis of favourable course in a patient with renal transplantation].
Le Cacheux P; Hurault de Ligny B; Reman O; Ryckelynck JP
Rev Med Interne; 1990; 11(3):250-1. PubMed ID: 2096427
[TBL] [Abstract][Full Text] [Related]
4. Leishmaniasis: a rare cause of unexplained fever in a renal graft recipient.
Moulin B; Ollier J; Bouchouareb D; Purgus R; Olmer M
Nephron; 1992; 60(3):360-2. PubMed ID: 1565190
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of visceral leishmaniasis with allopurinol plus ketoconazole in an infant who developed pancreatitis caused by meglumine antimoniate.
Kuyucu N; Kara C; Bakirtaç A; Teziç T
Pediatr Infect Dis J; 2001 Apr; 20(4):455-7. PubMed ID: 11332679
[TBL] [Abstract][Full Text] [Related]
6. Visceral leishmaniasis in a renal transplant recipient: diagnostic and therapeutic problems.
Sharma RK; Jha R; Kumar P; Kher V; Gupta A; Kumar A; Gulati S; Arora P; Murari M; Bhandari M
Am J Nephrol; 1996; 16(4):358-60. PubMed ID: 8739293
[TBL] [Abstract][Full Text] [Related]
7. The renal transplant patient with visceral leishmaniasis who could not tolerate meglumine antimoniate-cure with ketoconazole and allopurinol.
Hueso M; Bover J; Serón D; Gil-Vernet S; Rufí G; Alsina J; Grinyó JM
Nephrol Dial Transplant; 1999 Dec; 14(12):2941-3. PubMed ID: 10570102
[No Abstract] [Full Text] [Related]
8. Visceral leishmaniasis in a renal transplant recipient treated with allopurinol.
Harzallah K; Belhadj R; Jemli B; Haloues M; Berraies N; Gargouri S; Hmida J; Battikh R; Manaa J
Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):105-8. PubMed ID: 20061702
[TBL] [Abstract][Full Text] [Related]
9. [Visceral leishmaniasis: a possible diagnosis in Belgium].
Desmyttere S; Hachimi-Idrissi S; Otten J
Tijdschr Kindergeneeskd; 1993 Oct; 61(5):182-5. PubMed ID: 8266313
[TBL] [Abstract][Full Text] [Related]
10. Visceral leishmaniasis (Kala-Azar) in transplant recipients: case report and review.
Berenguer J; Gómez-Campderá F; Padilla B; Rodríguez-Ferrero M; Anaya F; Moreno S; Valderrábano F
Transplantation; 1998 May; 65(10):1401-4. PubMed ID: 9625028
[TBL] [Abstract][Full Text] [Related]
11. Visceral leishmaniasis and renal tuberculosis in a patient on maintenance haemodialysis.
Peces R; de la Torre M; Alcázar R
Nephrol Dial Transplant; 1996 Apr; 11(4):707-8. PubMed ID: 8671866
[No Abstract] [Full Text] [Related]
12. [Treatment of visceral leishmaniasis in children].
Minodier P; Noël G; Blanc P; Uters M; Retornaz K; Garnier JM
Med Trop (Mars); 2007 Feb; 67(1):73-8. PubMed ID: 17506279
[TBL] [Abstract][Full Text] [Related]
13. [Association of acute lymphoblastic leukaemia and visceral leishmaniasis].
Nafil H; Tazi I; Mahmal L
Ann Biol Clin (Paris); 2011; 69(6):729-31. PubMed ID: 22123576
[TBL] [Abstract][Full Text] [Related]
14. Prophylaxis of visceral leishmaniasis in human immunodeficiency virus-infected patients.
Ribera E; Ocaña I; de Otero J; Cortes E; Gasser I; Pahissa A
Am J Med; 1996 May; 100(5):496-501. PubMed ID: 8644760
[TBL] [Abstract][Full Text] [Related]
15. Acute pancreatitis associated with the administration of meglumine antimonate for the treatment of visceral leishmaniasis.
de Lalla F; Pellizzer G; Gradoni L; Vespignani M; Franzetti M; Stecca C
Clin Infect Dis; 1993 May; 16(5):730-1. PubMed ID: 8507769
[No Abstract] [Full Text] [Related]
16. Evolution of serum albumin/globulin ratio after antimonial therapy in canine leishmaniasis.
Amusategui I; Sainz A; Tesouro MA
Ann N Y Acad Sci; 1998 Jun; 849():447-9. PubMed ID: 9668510
[No Abstract] [Full Text] [Related]
17. [Visceral kala-azar of Spanish origin. Apropos of a case].
De Caluwé JP; Lievens P; Trolin C; Heimann R; Delcourt A; Taelman H
Acta Clin Belg; 1988; 43(5):349-55. PubMed ID: 3061269
[No Abstract] [Full Text] [Related]
18. High frequency of serious side effects from meglumine antimoniate given without an upper limit dose for the treatment of visceral leishmaniasis in human immunodeficiency virus type-1-infected patients.
Delgado J; Macías J; Pineda JA; Corzo JE; González-Moreno MP; de la Rosa R; Sánchez-Quijano A; Leal M; Lissen E
Am J Trop Med Hyg; 1999 Nov; 61(5):766-9. PubMed ID: 10586909
[TBL] [Abstract][Full Text] [Related]
19. Visceral Leishmaniasis in Renal Transplant Recipients: Report of 2 Cases.
Clavijo Sánchez F; Vázquez Sánchez T; Cabello Díaz M; Sola Moyano VE; Jironada Gallego C; Hernández Marrero D
Transplant Proc; 2018 Mar; 50(2):581-582. PubMed ID: 29579858
[TBL] [Abstract][Full Text] [Related]
20. [Pancreatitis during treatment of leishmaniasis with n-methylglucamine antimoniate in a subject infected with HIV].
Trinchieri V; Ferone U; Monacelli M; Isceri L; Proietti F; Sorice F
Riv Eur Sci Med Farmacol; 1996; 18(2):49-51. PubMed ID: 9213843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
